Primex Clinical Laboratories, Inc.
11
Martin R. Barash
10/10/2023
04/01/2025
Yes
v
Assigned to: Martin R. Barash Chapter 11 Voluntary Asset Debtor disposition: Standard Discharge |
|
Debtor Primex Clinical Laboratories, Inc.
16742 Stagg Street Suite 120 Van Nuys, CA 91406 LOS ANGELES-CA Tax ID / EIN: 95-4574505 |
represented by |
Garrick A Hollander
Winthrop Golubow Hollander, LLP 1301 Dove Street, Suite 500 Newport Beach, CA 92660 949-720-4150 Fax : 949-720-4111 Email: ghollander@wghlawyers.com Peter W Lianides
Winthrop Golubow Hollander, LLP 1301 Dove Street, Suite 500 Newport Beach, CA 92660 949-720-4100 Fax : 949-720-4111 Email: plianides@wghlawyers.com Robert E Opera
Winthrop Golubow Hollander, LLP 1301 Dove Street, Suite 500 Newport Beach, CA 92660 949-720-4100 Email: ropera@wghlawyers.com Matthew J Stockl
Winthrop Golubow Hollander, LLP 1301 Dove Street Suite 500 Newport Beach, CA 92660 949-720-4100 Email: matthew.stockl@dinsmore.com |
U.S. Trustee United States Trustee (SV)
915 Wilshire Blvd, Suite 1850 Los Angeles, CA 90017 (213) 894-6811 |
represented by |
Russell Clementson
915 Wilshire Blvd., Suite 1850 Los Angeles, CA 90017 213-894-4505 Fax : 213-894-0276 Email: russell.clementson@usdoj.gov |
Date Filed | # | Docket Text |
---|---|---|
04/01/2025 | 265 | Hearing Set (RE: related document(s)261 Application for Compensation filed by Debtor Primex Clinical Laboratories, Inc.) The Hearing date is set for 4/29/2025 at 01:30 PM at Crtrm 303, 21041 Burbank Blvd, Woodland Hills, CA 91367. The case judge is Martin R. Barash (PG) (Entered: 04/01/2025) |
04/01/2025 | 264 | Hearing Set (RE: related document(s)260 Application for Compensation filed by Debtor Primex Clinical Laboratories, Inc.) The Hearing date is set for 4/29/2025 at 01:30 PM at Crtrm 303, 21041 Burbank Blvd, Woodland Hills, CA 91367. The case judge is Martin R. Barash (PG) (Entered: 04/01/2025) |
04/01/2025 | 263 | Supplemental Notice re: Availability of ZoomGov Audio and Video For Remote Appearance [260/261] Filed by Debtor Primex Clinical Laboratories, Inc.. (Hollander, Garrick) (Entered: 04/01/2025) |
04/01/2025 | 262 | Notice of Hearing Notice To Creditors And Parties-In-Interest Of Hearing On Second And Final Application For Compensation And Reimbursement Of Expenses Of Winthrop Golubow Hollander, LLP, General Insolvency Counsel To Debtor And Debtor-In-Possession And Wilshire Pacific Capital Advisors, Chief Restructuring Officer Of Debtor And Debtor-In-Possession Filed by Debtor Primex Clinical Laboratories, Inc. (RE: related document(s)260 Application for Compensation Second And Final Application For Compensation And Reimbursement Of Expenses Of Winthrop Golubow Hollander, LLP, General Insolvency Counsel To Debtor And Debtor-In-Possession; Memorandum Of Points And Authorities; And Declarations Of Garrick A. Hollander And Eric J. Weissman In Support Thereof for Garrick A Hollander, Debtor's Attorney, Period: 11/1/2024 to 12/31/2024, Fee: $162299, Expenses: $5478.19. Filed by, 261 Application for Compensation Second And Final Application For Compensation And Reimbursement Of Expenses Of Wilshire Pacific Capital Advisors, Chief Restructuring Officer Of Debtor And Debtor-In-Possession for Garrick A Hollander, Other Professional, Period: 11/1/2024 to 12/31/2024, Fee: $110,500, Expenses: $. Filed by). (Hollander, Garrick) (Entered: 04/01/2025) |
04/01/2025 | 261 | Application for Compensation Second And Final Application For Compensation And Reimbursement Of Expenses Of Wilshire Pacific Capital Advisors, Chief Restructuring Officer Of Debtor And Debtor-In-Possession for Garrick A Hollander, Other Professional, Period: 11/1/2024 to 12/31/2024, Fee: $110,500, Expenses: $. Filed by (Hollander, Garrick) (Entered: 04/01/2025) |
04/01/2025 | 260 | Application for Compensation Second And Final Application For Compensation And Reimbursement Of Expenses Of Winthrop Golubow Hollander, LLP, General Insolvency Counsel To Debtor And Debtor-In-Possession; Memorandum Of Points And Authorities; And Declarations Of Garrick A. Hollander And Eric J. Weissman In Support Thereof for Garrick A Hollander, Debtor's Attorney, Period: 11/1/2024 to 12/31/2024, Fee: $162299, Expenses: $5478.19. Filed by (Hollander, Garrick) (Entered: 04/01/2025) |
03/28/2025 | 259 | Notice to Filer of Error and/or Deficient Document Incorrect docket event was used to file this document. No fee applications pending. NO ACTION TAKEN. (RE: related document(s)255 Notice of Hearing (BK Case) filed by Debtor Primex Clinical Laboratories, Inc., 256 Supplemental filed by Debtor Primex Clinical Laboratories, Inc.) (JC) (Entered: 03/28/2025)THE FILER IS INSTRUCTED TO RE-FILE THE DOCUMENT USING THE CORRECT DOCKET EVENT. |
03/28/2025 | 258 | Notice to Filer of Error and/or Deficient Document Incorrect docket event was used to file this document. This document appears to be a declaration in support of a previously resolved fee application. If this is intended to be a supplemental fee application, please use the correct event code "Compensation (motion)." It also may not be linked to a prior, resolved motion. Additionally, an incorrect hearing date was selected. (RE: related document(s)254 Supplemental filed by Debtor Primex Clinical Laboratories, Inc.) (JC) (Entered: 03/28/2025)THE FILER IS INSTRUCTED TO RE-FILE THE DOCUMENT USING THE CORRECT DOCKET EVENT. |
03/28/2025 | 257 | Notice to Filer of Error and/or Deficient Document Incorrect docket event was used to file this document. This document appears to be a supplemental fee application and should be filed using the event code "Compensation (motion)." It also may not be linked to a prior, resolved motion. Additionally, an incorrect hearing date was selected. (RE: related document(s)253 Supplemental filed by Debtor Primex Clinical Laboratories, Inc.) (JC) (Entered: 03/28/2025)THE FILER IS INSTRUCTED TO RE-FILE THE DOCUMENT USING THE CORRECT DOCKET EVENT. |
03/27/2025 | 256 | Supplemental Supplemental Notice Re: Availability Of ZoomGov Audio And Video For Remote Appearance [253,254,255] Filed by Debtor Primex Clinical Laboratories, Inc.. (Hollander, Garrick) (Entered: 03/27/2025) |